Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1956 1
1978 1
1979 2
1982 1
1983 1
1984 1
1985 1
1986 3
1987 3
1988 4
1989 3
1990 3
1991 5
1992 4
1993 4
1994 8
1995 6
1996 6
1997 9
1998 7
1999 4
2000 8
2001 1
2002 5
2003 6
2004 5
2005 7
2006 7
2007 3
2008 1
2009 4
2010 3
2011 3
2012 7
2013 5
2014 9
2015 8
2016 12
2017 14
2018 11
2019 14
2020 13
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

217 results
Results by year
Filters applied: . Clear all
Page 1
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1.
Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, Jedrychowski MP, Costa ASH, Higgins M, Hams E, Szpyt J, Runtsch MC, King MS, McGouran JF, Fischer R, Kessler BM, McGettrick AF, Hughes MM, Carroll RG, Booty LM, Knatko EV, Meakin PJ, Ashford MLJ, Modis LK, Brunori G, Sévin DC, Fallon PG, Caldwell ST, Kunji ERS, Chouchani ET, Frezza C, Dinkova-Kostova AT, Hartley RC, Murphy MP, O'Neill LA. Mills EL, et al. Among authors: ashford mlj. Nature. 2018 Apr 5;556(7699):113-117. doi: 10.1038/nature25986. Epub 2018 Mar 28. Nature. 2018. PMID: 29590092 Free PMC article.
Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS, Harrison DJ, Kisielewski D, Cassidy DM, McNeilly AD, Gallagher JR, Walsh SV, Honda T, McCrimmon RJ, Dinkova-Kostova AT, Ashford MLJ, Dillon JF, Hayes JD. Sharma RS, et al. Among authors: ashford mlj. Cell Mol Gastroenterol Hepatol. 2017 Dec 13;5(3):367-398. doi: 10.1016/j.jcmgh.2017.11.016. eCollection 2018 Mar. Cell Mol Gastroenterol Hepatol. 2017. PMID: 29552625 Free PMC article.
Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction.
Meakin PJ, Coull BM, Tuharska Z, McCaffery C, Akoumianakis I, Antoniades C, Brown J, Griffin KJ, Platt F, Ozber CH, Yuldasheva NY, Makava N, Skromna A, Prescott A, McNeilly AD, Siddiqui M, Palmer CN, Khan F, Ashford ML. Meakin PJ, et al. Among authors: ashford ml. J Clin Invest. 2020 Aug 3;130(8):4104-4117. doi: 10.1172/JCI122237. J Clin Invest. 2020. PMID: 32407295 Free PMC article.
Drug delivery-the increasing momentum.
Ashford M. Ashford M. Drug Deliv Transl Res. 2020 Dec;10(6):1888-1894. doi: 10.1007/s13346-020-00858-6. Epub 2020 Oct 6. Drug Deliv Transl Res. 2020. PMID: 33025537
Critical considerations for targeting colorectal liver metastases with nanotechnology.
Arshad U, Sutton PA, Ashford MB, Treacher KE, Liptrott NJ, Rannard SP, Goldring CE, Owen A. Arshad U, et al. Among authors: ashford mb. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1588. doi: 10.1002/wnan.1588. Epub 2019 Sep 30. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020. PMID: 31566913 Free PMC article. Review.
Penetration and Uptake of Nanoparticles in 3D Tumor Spheroids.
Tchoryk A, Taresco V, Argent RH, Ashford M, Gellert PR, Stolnik S, Grabowska A, Garnett MC. Tchoryk A, et al. Among authors: ashford m. Bioconjug Chem. 2019 May 15;30(5):1371-1384. doi: 10.1021/acs.bioconjchem.9b00136. Epub 2019 Apr 12. Bioconjug Chem. 2019. PMID: 30946570
217 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page